Allogeneic stem cell transplantation for advanced primary cutaneous T-cell lymphoma: A systematic review

1 Safety and activity of crizotinib for paediatric patients with refractory solid tumours or anaplastic large-cell lymphoma: a Childrens Oncology Group phase 1 consortium study The Lancet Oncology, April 24, 2013

2 Multicenter phase II study of bendamustine plus rituximab in patients with relapsed or refractory diffuse large B-cell lymphoma Journal of Clinical Oncology, May 9, 2013

3 Estimated risk of cardiovascular disease and secondary cancers with modern highly conformal radiotherapy for early-stage mediastinal Hodgkin lymphoma Annals of Oncology, May 6, 2013

4 Japonicone a suppresses growth of Burkitt lymphoma cells through its effect on NF-kappaB Clinical Cancer Research, May 15, 2013

5 Safety and activity of crizotinib for paediatric patients with refractory solid tumours or anaplastic large-cell lymphoma: a Children's Oncology Group phase 1 consortium study The Lancet Oncology, May 3, 2013

6 Dose-dense rituximab-CHOP compared with standard rituximab-CHOP in elderly patients with diffuse large B-cell lymphoma (the LNH03-6B study): a randomised phase 3 trial The Lancet Oncology, May 3, 2013

7 The epidemic of non-Hodgkin lymphoma in the United States: Disentangling the effect of HIV, 1992-2009 Cancer Epidemiology, Biomarkers & Prevention, April 25, 2013

8 Clinical, virologic, and immunologic outcomes in lymphoma survivors and in cancer-free, HIV-1-infected patients Cancer, April 29, 2013

9 Physical activity and risk of lymphoma: a meta-analysis Cancer Epidemiology, Biomarkers & Prevention, May 20, 2013    Review Article

10 Solar UV radiation and cancer in young children Cancer Epidemiology, Biomarkers & Prevention, May 20, 2013